NCT07450183 2026-03-04Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1Henry Ford Health SystemPhase 2 Not yet recruiting33 enrolled
NCT06943664 2026-02-18Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 2 Not yet recruiting27 enrolled